The news informing a premium flu vaccine is ‘free’

Novartis’s ‘Fluad,’ which debuted as a seasonal premium flu vaccine for elders over 65, has been largely supplied through the ‘National Immunization Program(NIP)’ this season.

Although Fluad was recognized as a premium-level flu vaccine with its price twice expensive than regular flu vaccines at its launch in 2010, the product, which were unable to create a premium market, is now facing a ‘fat...